Group 1: Product Performance - The sales growth of the L-carnitine series products is primarily due to the restoration of the production line and an increase in market demand [1] - The company will not enter the medical beauty industry in the short term but will assist clients in expanding the application scenarios of L-carnitine products [1] Group 2: Market Potential - The demand for alpha-lipoic acid products is currently mainly in overseas markets, particularly in Europe and the United States, where it remains a popular dietary supplement [1] - If alpha-lipoic acid can obtain health food certification in China, the domestic market demand is expected to increase significantly [1] Group 3: Pricing Strategy - Since 2014, the price of alpha-lipoic acid products has shown a steady upward trend, with moderate price increases accepted by customers [2] - The company cannot raise prices indefinitely, as excessive increases may motivate customers to change formulations and seek alternatives [2]
富士莱(301258) - 2022年8月1日投资者关系活动记录表